Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 4, 2009 (rev. 1)

Premium

Stephane Perrey will serve as president of Qiagen KK, Qiagen's Tokyo subsidiary. He is taking over for Kazuo Tokushige, who retired on Dec. 31. Perrey formerly worked at Third Wave/Hologic Japan and he held various positions in Japan's in vitro diagnostic industry.


Allen Bombard has accepted the job of chief medical officer at Sequenom. In the role, Bombard will oversee the company's clinical and medical affairs.

Formerly, Bombard was CEO at Lenetix, CMO at Sharp Mary Birch Hospital in San Diego, and he was senior VP and director of the residency program in obstetrics and gynecology at Lutheran Medical Center in Brooklyn, NY. He also has served as a medical director for women's health at Aetna, and he was director of the Department of Obstetrics and Gynecology and Women's Health at Montefiore Medical Center and the Albert Einstein College of Medicine in Bronx, NY.


ParagonDx announced Jorge Leon has joined its scientific advisory board. Leon was one of the founders of Quest's molecular diagnostics and applied genomics business. He held several positions at Quest, including director of molecular diagnostics and VP of applied genomics.

In 2003, Leon founded Leomics Associates, a consulting firm specializing in helping start-ups, academic centers, and established companies build and commercialize innovative business strategies, product pipelines and test menus.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.